Clinical Trials Browser

Cholangiocarcinoma × Afatinib × Gastrointestinal × Clear all

NCT06302621 2026-01-15

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

Phase 1 Recruiting

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma